Literature DB >> 9207631

Attenuation of severity of myocardial ischemia during repeated daily ischemic episodes.

D Tzivoni1, S Maybaum.   

Abstract

OBJECTIVES: The purpose of this study was to assess whether the severity of myocardial ischemia would be attenuated by repeated daily ischemic episodes, recorded by ambulatory electrocardiographic monitoring (AEM).
BACKGROUND: Repetitive ischemic episodes induced by brief coronary occlusions in animal experiments and in humans during balloon coronary angioplasty produce preconditioning. We wanted to assess whether this phenomenon also exists during daily ischemic episodes.
METHODS: Twenty-one patients with known coronary artery disease and ischemia on exercise testing and AEM were requested to walk a distance known to have previously caused myocardial ischemia on three consecutive occasions. Walking time was approximately 15 min and was followed by 5 min of rest.
RESULTS: Mean maximal heart rate during the three walks was similar; however, the mean maximal ST segment depression decreased significantly from 2.21 mm during the first walk to 1.61 mm and 1.43 mm, respectively, on the second and third walks (p = 0.001). Ischemia duration was also significantly reduced on the second and third walks by 56% from 514 to 228 and 254 s, respectively (p = 0.012). The heart rate at onset of ischemia (ischemic threshold) increased from 99 beats/min on the first walk to 101 beats/min on the second walk and to 106 beats/min on the third walk (p = 0.058).
CONCLUSIONS: This study demonstrated attenuation of myocardial ischemia with an associated increase in ischemic threshold in patients with repeated and adjacent ischemic episodes. This form of myocardial protection is likely to be encountered in patients during ordinary activity and may represent the clinical counterpart of myocardial preconditioning.

Entities:  

Mesh:

Year:  1997        PMID: 9207631     DOI: 10.1016/s0735-1097(97)00120-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  4 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

2.  Myocardial ischemic preconditioning during minimally invasive direct coronary artery bypass grafting attenuates ischemia-induced electrophysiological changes in human ventricle.

Authors:  Yoshio Doi; Go Watanabe; Keiju Kotoh; Katsushi Ueyama; Takuro Misaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-04

3.  Level of Physical Activity and In-Hospital Course of Patients with Acute Coronary Syndrome.

Authors:  Juliana de Goes Jorge; Marcos Antonio Almeida Santos; José Augusto Soares Barreto Filho; Joselina Luzia Menezes Oliveira; Enaldo Vieira de Melo; Norma Alves de Oliveira; Gustavo Baptista de Almeida Faro; Antônio Carlos Sobral Sousa
Journal:  Arq Bras Cardiol       Date:  2015-12-22       Impact factor: 2.000

4.  Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.

Authors:  Andrew J Morrow; Thomas J Ford; Kenneth Mangion; Tushar Kotecha; Roby Rakhit; Gavin Galasko; Stephen Hoole; Anthony Davenport; Rajesh Kharbanda; Vanessa M Ferreira; Mayooran Shanmuganathan; Amedeo Chiribiri; Divaka Perera; Haseeb Rahman; Jayanth R Arnold; John P Greenwood; Michael Fisher; Dirk Husmeier; Nicholas A Hill; Xiaoyu Luo; Nicola Williams; Laura Miller; Jill Dempster; Peter W Macfarlane; Paul Welsh; Naveed Sattar; Andrew Whittaker; Alex Mc Connachie; Sandosh Padmanabhan; Colin Berry
Journal:  Am Heart J       Date:  2020-07-17       Impact factor: 4.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.